• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CSK-DEX-PLGA 纳米粒的合成及其用于艾塞那肽口服给药以改善其黏膜穿透和肠道吸收

Synthesis of CSK-DEX-PLGA Nanoparticles for the Oral Delivery of Exenatide to Improve Its Mucus Penetration and Intestinal Absorption.

机构信息

School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong , Yantai University , Yantai 264005 , China.

School of Pharmacy , Binzhou Medical University , Yantai 264005 , China.

出版信息

Mol Pharm. 2019 Feb 4;16(2):518-532. doi: 10.1021/acs.molpharmaceut.8b00809. Epub 2019 Jan 14.

DOI:10.1021/acs.molpharmaceut.8b00809
PMID:30601014
Abstract

The oral absorption of exenatide, a drug for type 2 diabetes treatment, can be improved by using nanoparticles (NPs) for its delivery. To improve the mucus penetration and intestinal absorption of exenatide, we designed a block copolymer, CSKSSDYQC-dextran-poly(lactic-co-glycolic acid) (CSK-DEX-PLGA), and used it for the preparation of exenatide-loaded NPs. The functionalized exenatide-loaded NPs composed of CSK-DEX-PLGA were able to target intestinal epithelial cells and reduce the mucus-blocking effect of the intestine. Moreover, the CSK modification of DEX-PLGA was found to significantly promote the absorption efficiency of NPs in the small intestine based on in vitro ligation of the intestinal rings and an examination of different intestinal absorption sites. Compared to DEX-PLGA-NPs (DPs), the absorption of CSK-DEX-PLGA-NPs (CDPs) was increased in the villi, allowing the drug to act on gobletlike Caco-2 cells through clathrin-, caveolin-, and gap-mediated endocytosis. Furthermore, the enhanced transport ability of CDPs was observed in a study on Caco-2/HT-29-MTX cocultured cells. CDPs exhibited a prolonged hypoglycemic response with a relative bioavailability of 9.2% in diabetic rats after oral administration. In conclusion, CDPs can target small intestinal goblet cells and have a beneficial effect on the oral administration of macromolecular peptides as a nanometer-sized carrier.

摘要

用于 2 型糖尿病治疗的药物艾塞那肽的口服吸收可以通过使用纳米颗粒(NPs)来提高其递送效率。为了提高艾塞那肽的黏液穿透和肠道吸收能力,我们设计了一种嵌段共聚物 CSKSSDYQC-葡聚糖-聚(乳酸-共-乙醇酸)(CSK-DEX-PLGA),并将其用于制备载艾塞那肽的 NPs。由 CSK-DEX-PLGA 组成的功能化载艾塞那肽 NPs 能够靶向肠道上皮细胞并减少肠道的黏液阻塞作用。此外,发现 DEX-PLGA 上的 CSK 修饰可显著提高 NPs 在小肠中的吸收效率,这是基于对肠环的体外连接和对不同肠道吸收部位的检查。与 DEX-PLGA-NPs(DPs)相比,CSK-DEX-PLGA-NPs(CDPs)在绒毛中的吸收增加,使药物能够通过网格蛋白、小窝蛋白和间隙介导的内吞作用作用于杯状 Caco-2 细胞。此外,在 Caco-2/HT-29-MTX 共培养细胞的研究中观察到 CDPs 的增强转运能力。在糖尿病大鼠口服给药后,CDPs 表现出延长的降血糖反应,相对生物利用度为 9.2%。总之,CDPs 可以靶向小肠杯状细胞,并作为纳米级载体对大分子肽的口服给药具有有益作用。

相似文献

1
Synthesis of CSK-DEX-PLGA Nanoparticles for the Oral Delivery of Exenatide to Improve Its Mucus Penetration and Intestinal Absorption.CSK-DEX-PLGA 纳米粒的合成及其用于艾塞那肽口服给药以改善其黏膜穿透和肠道吸收
Mol Pharm. 2019 Feb 4;16(2):518-532. doi: 10.1021/acs.molpharmaceut.8b00809. Epub 2019 Jan 14.
2
Oral delivery system for low molecular weight protamine-dextran-poly(lactic-co-glycolic acid) carrying exenatide to overcome the mucus barrier and improve intestinal targeting efficiency.携带艾塞那肽的低分子质量鱼精蛋白-葡聚糖-聚(乳酸-共-乙醇酸)口服递药系统,以克服黏液屏障并提高肠道靶向效率。
Nanomedicine (Lond). 2019 Apr;14(8):989-1009. doi: 10.2217/nnm-2018-0322.
3
Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.用于口服胰岛素传递的杯状细胞靶向纳米颗粒,以及黏液对胰岛素传递的影响。
Biomaterials. 2012 Feb;33(5):1573-82. doi: 10.1016/j.biomaterials.2011.10.075. Epub 2011 Nov 16.
4
Tf ligand-receptor-mediated exenatide-Zn complex oral-delivery system for penetration enhancement of exenatide.Tf 配体-受体介导的 exenatide-Zn 复合物口服递药系统增强 exenatide 的穿透性。
J Drug Target. 2018 Dec;26(10):931-940. doi: 10.1080/1061186X.2018.1455839. Epub 2018 Apr 16.
5
N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.N-三甲基壳聚糖盐酸盐包覆的 PLGA 纳米粒克服口服胰岛素吸收的多重障碍。
ACS Appl Mater Interfaces. 2015 Jul 22;7(28):15430-41. doi: 10.1021/acsami.5b03555. Epub 2015 Jul 9.
6
Utilization of PLGA nanoparticles in yeast cell wall particle system for oral targeted delivery of exenatide to improve its hypoglycemic efficacy.利用 PLGA 纳米粒在酵母细胞壁颗粒系统中口服靶向递送艾塞那肽,以提高其降血糖效果。
Int J Pharm. 2021 May 15;601:120583. doi: 10.1016/j.ijpharm.2021.120583. Epub 2021 Apr 9.
7
N-trimethyl chitosan nanoparticles and CSKSSDYQC peptide: N-trimethyl chitosan conjugates enhance the oral bioavailability of gemcitabine to treat breast cancer.三甲基壳聚糖纳米粒和 CSKSSDYQC 肽:三甲基壳聚糖缀合物提高吉西他滨的口服生物利用度,用于治疗乳腺癌。
J Control Release. 2018 May 10;277:142-153. doi: 10.1016/j.jconrel.2018.03.013. Epub 2018 Mar 13.
8
The use of low molecular weight protamine to enhance oral absorption of exenatide.低分子鱼精蛋白增强艾塞那肽口服吸收的作用。
Int J Pharm. 2018 Aug 25;547(1-2):265-273. doi: 10.1016/j.ijpharm.2018.05.055. Epub 2018 May 23.
9
The glucose-lowering potential of exenatide delivered orally via goblet cell-targeting nanoparticles.通过靶向杯状细胞的纳米颗粒口服递送的艾塞那肽的降血糖潜力。
Pharm Res. 2015 Mar;32(3):1017-27. doi: 10.1007/s11095-014-1513-1. Epub 2014 Oct 1.
10
Prediction of the enhanced insulin absorption across a triple co-cultured intestinal model using mucus penetrating PLGA nanoparticles.使用穿透黏液的 PLGA 纳米粒预测三重共培养肠模型中的增强胰岛素吸收。
Int J Pharm. 2020 Jul 30;585:119516. doi: 10.1016/j.ijpharm.2020.119516. Epub 2020 Jun 7.

引用本文的文献

1
Targeting granulosa cells with engineered DFO nanoparticles for the treatment of chemotherapy-induced premature ovarian failure.利用工程化去铁胺纳米颗粒靶向颗粒细胞治疗化疗诱导的卵巢早衰。
Theranostics. 2025 Jul 4;15(15):7820-7840. doi: 10.7150/thno.115416. eCollection 2025.
2
Cold Exposure and Oral Delivery of GLP-1R Agonists by an Engineered Probiotic Yeast Strain Have Antiobesity Effects in Mice.冷暴露和经工程改造的益生菌酵母菌株经口递送 GLP-1R 激动剂对小鼠具有抗肥胖作用。
ACS Synth Biol. 2023 Nov 17;12(11):3433-3442. doi: 10.1021/acssynbio.3c00455. Epub 2023 Oct 12.
3
Flexible Monitoring, Diagnosis, and Therapy by Microneedles with Versatile Materials and Devices toward Multifunction Scope.
采用多功能材料和装置的微针实现多功能范围内的灵活监测、诊断和治疗。
Research (Wash D C). 2023 Apr 28;6:0128. doi: 10.34133/research.0128. eCollection 2023.
4
Folic acid-modified reverse micelle-lipid nanocapsules overcome intestinal barriers and improve the oral delivery of peptides.叶酸修饰的反胶束-脂质纳米胶囊克服肠道屏障,提高肽类的口服递送。
Drug Deliv. 2023 Dec;30(1):2181744. doi: 10.1080/10717544.2023.2181744.
5
Improved systemic half-life of glucagon-like peptide-1-loaded carbonate apatite nanoparticles in rats.大鼠体内负载胰高血糖素样肽-1的碳酸磷灰石纳米颗粒的全身半衰期延长
World J Diabetes. 2022 Aug 15;13(8):613-621. doi: 10.4239/wjd.v13.i8.613.
6
Biomaterials and Extracellular Vesicle Delivery: Current Status, Applications and Challenges.生物材料和细胞外囊泡递送:现状、应用和挑战。
Cells. 2022 Sep 13;11(18):2851. doi: 10.3390/cells11182851.
7
Repositioning of drugs for Parkinson's disease and pharmaceutical nanotechnology tools for their optimization.帕金森病药物的再定位和药物纳米技术工具及其优化。
J Nanobiotechnology. 2022 Sep 15;20(1):413. doi: 10.1186/s12951-022-01612-5.
8
Two-Layer Sustained-Release Microneedles Encapsulating Exenatide for Type 2 Diabetes Treatment.用于2型糖尿病治疗的包裹艾塞那肽的双层缓释微针
Pharmaceutics. 2022 Jun 13;14(6):1255. doi: 10.3390/pharmaceutics14061255.
9
Nanoscale bioconjugates: A review of the structural attributes of drug-loaded nanocarrier conjugates for selective cancer therapy.纳米级生物偶联物:用于选择性癌症治疗的载药纳米载体偶联物的结构属性综述。
Heliyon. 2022 Jun 2;8(6):e09577. doi: 10.1016/j.heliyon.2022.e09577. eCollection 2022 Jun.
10
Advances in oral peptide drug nanoparticles for diabetes mellitus treatment.用于糖尿病治疗的口服肽药物纳米颗粒的研究进展。
Bioact Mater. 2022 Feb 28;15:392-408. doi: 10.1016/j.bioactmat.2022.02.025. eCollection 2022 Sep.